Cardiovascular Consequences of Weightlessness Promote Advances in Clinical and Trauma Care

E-ISSN： 1873-4316|6|4|285-297

ISSN： 1389-2010

Source： Current Pharmaceutical Biotechnology, Vol.6, Iss.4, 2005-08, pp. : 285-297

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Editorial (Hot Topic: New Insights into Insulin Resistance, Cardiovascular Diseases and Oxidative Stress: Pathophysiological and Clinical Consequences)

Current Pharmaceutical Design, Vol. 19, Iss. 32, 2013-10 ,pp. : 5661-5662

Bentham Science Publishers

Access to resources Recommend Favorite

Clinical consequences of polypharmacy in elderly

By Maher Robert L Hanlon Joseph Hajjar Emily R

Expert Opinion on Drug Safety, Vol. 13, Iss. 1, 2014-01 ,pp. : 57-65

Informa Healthcare

Access to resources Recommend Favorite

Long-Term Consequences of Drugs on the Paediatric Cardiovascular System

By Hausner Elizabeth Fiszman Monica L. Hanig Joseph Harlow Patricia Zornberg Gwen Sobel Solomon

Drug Safety, Vol. 31, Iss. 12, 2008-01 ,pp. : 1083-1096

Adis International

Access to resources Recommend Favorite

Cardiovascular consequences of the obesity pandemic: need for action

By Barton Matthias Furrer Jörg

Expert Opinion on Investigational Drugs, Vol. 12, Iss. 11, 2003-11 ,pp. : 1757-1759

Informa Healthcare

Access to resources Recommend Favorite

Cardiovascular Disease and Therapeutic Drug-Related Cardiovascular Consequences in HIV-Infected Patients

By Fisher Stacy D.

American Journal of Cardiovascular Drugs, Vol. 11, Iss. 6, 2011-12 ,pp. : 383-394

Adis International

Access to resources Recommend Favorite